For Healthcare Professionals: Melanoma: Related News

On Our Blog

Pictured: Jedd Wolchok
Combining Two FDA-Approved Drugs May Be Harmful for Patients with Metastatic Melanoma

Early research led by investigators at Memorial Sloan Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.

April 4, 2013
Pictured: Jedd Wolchok & Richard Carvajal
Memorial Sloan Kettering Researchers Report on Major Advances in the Treatment of Metastatic Eye and Skin Melanoma

Two Memorial Sloan Kettering studies that hold promise for the treatment of advanced uveal (eye) melanoma and advanced skin melanoma are making headlines at the 49th Annual Meeting of the American Society of Clinical Oncology.

June 3, 2013

Clinical Updates